Rhoenix gets emergency clearance for COVID-19 assay

By LabPulse.com staff writers

The U.S. Food and Drug Administration (FDA) has granted molecular testing company Rhoenix emergency use authorization for a fully automated test to detect the presence of the novel coronavirus from respiratory samples.

The Rheonix COVID-19 MDx assay provides same-day results for COVID-19 testing, according to the company. The automated workflow doesn't need the assistance of a technician and can be done on-site at distributed locations.

The assay is designed for small- and medium-throughput laboratories and is compatible with the company's Encompass MDx workstation. Rheonix said that it has begun shipping both the workstation and test kits to hospital laboratories.

Copyright © 2020 LabPulse.com

To read this and get access to all of the exclusive content on LabPulse.com, create a free account or sign in now.

Member Sign In:
MemberID or email address:  
Do you have a LabPulse.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?